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Objective: To compare bioﬁlm formation in trimethoprim/sulfamethoxazole (SXT)-
susceptible Escherichia coli (E. coli) (SSEC) and SXT-resistant E. coli (SREC) isolated
from patients with urinary tract infections, and study the motile ability and physical
characteristics of the isolates.
Methods: A total of 74 E. coli isolates were tested for antimicrobial susceptibility with the
disc diffusion assay. Based on the SXT-susceptibility test, the E. coli isolates were divided
into SSEC (N = 30) and SREC (N = 44) groups. All E. coli isolates were examined for motile
ability by using a motility test medium, and for checking bioﬁlm formation a scanning
electron microscope was used. Bacterial colony size was measured with a vernier caliper and
bacterial cell length was measured under a light microscope. The bacterial growth rate was
studied by plotting the cell growth (absorbance) versus the incubation time.
Results: The frequencies of non-motility and bioﬁlm formation in the SREC group were
signiﬁcantly higher than that in the SSEC group (P < 0.01). The SREC bacterial cell
length was shorter than that in the SSEC group [(1.35 ± 0.05) vs. (1.53 ± 0.05) mm,
P < 0.05)], whereas the bacterial colony size and mid-log phase of the growth curve were
not signiﬁcantly different.
Conclusions: The present study indicated that bioﬁlm formation and phenotypic change
of uropathogenic E. coli can be attributed to the mechanism of E. coli SXT resistance.1. Introduction
Urinary tract infections (UTIs) can develop into serious and
potentially life-threatening infections of the kidney [1,2].Escherichia coli (E. coli) is the most prevalent pathogen that
causes community-acquired (about 80%) and hospital-acquired
UTIs (more than 30%) [1–4]. Trimethoprim/sulfamethoxazole
(SXT) is an antimicrobial combination drug that is widely used
for the treatment of mild to moderate bacterial infections. It is
recommended in areas where the prevalence of SXT–resistant
pathogens does not exceed 20%. However, SXT resistance in
E. coli has substantially increased from 17.9% in 2000 to 24.2%
in 2010 in outpatients in the United States of America [5]. In
addition, E. coli is often isolated from the urine of kidney stone
patients with UTIs in the northeast of Thailand. These E. coli
isolates are frequently found to be multidrug resistant [6].
The ability of E. coli to persist and grow as bioﬁlms seems to
be an important factor involved in both the severity of UTIs and
antimicrobial resistance [7]. As the E. coli was protected within
the bacterial extracellular matrix, antimicrobial agents werean open access article under the CC BY-NC-ND
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uropathogenic E. coli isolates showed a signiﬁcant correlation
between bioﬁlm formation and resistance to multiple
antimicrobial drugs, such as ampicillin, amikacin, norﬂoxacin
and SXT. Bioﬁlm formation was increased in these E. coli
isolates [9]. However, the previous studies did not exclude
interfering factors, such as the ability of extended-spectrum b-
lactamase (ESBL) producers, and did not select the E. coli
isolates from the most compatible pattern of antimicrobial drug
resistance. To obtain more information about the SXT resistance
mechanism and its related factors, extensive analyses of changes
in the physical characteristics as well as bioﬁlm formation and
motile ability are required. Therefore, the aim of this study was
to compare bioﬁlm formation in SXT-susceptible E. coli (SSEC)
and SXT-resistant E. coli (SREC). The motile ability and
physical characteristics, including bacterial colony size, cell
length and growth rate, of the two groups were also evaluated.
2. Materials and methods
2.1. E. coli isolation and identiﬁcation
Urine specimens from UTI patients were obtained from
Srinagarind Hospital, Khon Kaen University between September
2012 and August 2013. Uropathogenic SXT-susceptible and
SXT-resistant E. coli isolates were collected after identiﬁcation
at the Clinical Microbiology Laboratory, Srinagarind Hospital.
The inclusion criteria were (i) pure isolation of E. coli; (ii)
bacterial colony count 105 CFU/mL; (iii) no multiple samples
from the same patient; and (iv) non ESBL producer.2.2. Antimicrobial susceptibility test
The antimicrobial susceptibility test on the selected E. coli
isolates was performed by the disc diffusion method. Five
antimicrobial agents were tested, which were amikacin (30 mg),
gentamicin (10 mg), cefotaxime (30 mg), ceftazidime (30 mg) and
SXT (1.25/23.75 mg) (Oxoid Ltd., Basingstoke, England), ac-
cording to the standard method of the Clinical and Laboratory
Standards Institute [10]. Identiﬁcation of ESBL-producing bac-
teria with resistance to third-generation cephalosporins was
determined by the double-disc diffusion test. Based on the SXT
susceptibility pattern, E. coli isolates were divided into two
groups: SSEC (susceptible to all ﬁve antimicrobial agents) and
SREC (susceptible to all antimicrobial agents except SXT)
groups. Both of them were non ESBL producers.
2.3. Motility test
Each E. coli isolate was inoculated in the motility test
medium (Bird Banding Laboratory, Maryland, USA) and
incubated at 37C for 24 h. A positive motility test was indi-
cated by a turbid area extending away from the line of inoc-
ulation. A negative test was indicated by growth along the
inoculation line.
2.4. Determination of bioﬁlm formation by scanning
electron microscope
Determination of bioﬁlm formation with a scanning electron
microscope was performed according to the modiﬁed method ofSalo et al [7]. Each E. coli isolate was cultured in tryptic soy
broth (TSB) (Oxoid Ltd., Basingstoke, England) overnight,
and the concentration was adjusted to 0.5 McFarland standard
(108 CFU/mL) with the same medium. One microliter of
E. coli suspension was then subcultured in 40 mL of TSB in a
sterilized 24-well plate; a sterilized glass slide (diameter
6 mm) was added into each well and incubated at 37 C for 48 h.
The culture medium was removed and the glass slide was ﬁxed
with 4% formaldehyde overnight. After removing the 4%
formaldehyde, the cells on the glass slide were dehydrated with
25%, 50%, 75% and 96% ethanol for 20 min each at room
temperature followed by air-drying. The cells were observed
under a scanning electron microscope (HITACHI S-3000N,
Hitachi Science Systems Ltd., Ibaraki, Japan). Positive bioﬁlm
formation was indicated by dense clusters of bacterial cells. A
negative result was indicated by interspersed cells.
2.5. Evaluation of bacterial colony size
A single colony of each E. coli isolate was cultured in TSB and
incubated for 24 h. After incubation, the E. coli suspension was
adjusted to 0.5 McFarland standard. Fifty microliters of E. coli
suspension was then spread onto MacConkey agar (Oxoid Ltd.,
Basingstoke, England) and incubated for 24 h. The diameters of all
colonies on the spread plate were measured with a vernier caliper.
2.6. Evaluation of bacterial cell length
A sterile needle was used to pick up bacteria from a single
colony on the same spread plate that was used for the bacterial
colony size evaluation. The needle was suspended in 1 mL of
distilled water, which was smeared on a glass slide
(1.2 cm× 1.2 cm) and stainedwith 0.25% safraninO. The length of
each cell in one ﬁeld of view was measured under a light micro-
scope (Nikon ECLIPSE 80i Microscope, Nikon Corporation,
Japan).
2.7. Mid-log phase of bacterial growth curve
All E. coli isolates were cultured onMacConkey agar for 24 h.
A single isolated colony from each strain was used to prepare a
bacterial suspension of 0.5 McFarland standard in TSB. These
suspensions were inoculated in a 96-well plate (200 mL/well)
(Nunclon™ Delta Surface, Thermo Fisher Scientiﬁc, Jiangsu,
China), and the optical density at 570 nm was recorded every
15 min for 12 h by a Tecan Sunrise plate reader (Tecan, Austria).
2.8. Ethics
This study was approved by the Ethics Committee of Khon
Kaen University (HE551307).
2.9. Statistical analysis
All data were reported as mean ± SE of the mean. Statistical
analysis was performed using SPSS software (version 17). To
test differences between two groups, Chi-square and student's t-
tests were used. Chi-square test was used to determine the
relationship between bioﬁlm formation and SXT resistance. A
P-value less than 0.05 was considered to be statistically
signiﬁcant.
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According to the selection criteria, 74 E. coli isolates were
included in this study. Based on the SXT susceptibility pattern,
the E. coli isolates were divided into two groups: SSEC (30
isolates) and SREC (44 isolates). To minimize bioﬁlm formation
from other interfering factors, none of the studied E. coli isolates
were ESBL producers and the SREC isolates were susceptible to
all antimicrobial agents except SXT. The motile ability and
bioﬁlm formation of the two groups were shown in Table 1.
Compared to the SSEC group, the SREC group showed a sta-
tistically signiﬁcant lower frequency for the motile ability
(P < 0.01) but higher frequency for bioﬁlm formation
(P < 0.01). Additionally, the data obtained from the both groups
demonstrated positive correlations between the bioﬁlm forma-
tion and SXT resistance (P < 0.05). The SREC cell length
[(1.35 ± 0.05) mm] was shorter than that of the SSEC group
[(1.53 ± 0.05) mm, P < 0.05]; whereas, the diameters of bacterial
colony and mid-log phase of the growth curve were not signif-
icantly different in both groups (Table 2).Table 1
Motile ability and bioﬁlm formation of SSEC (N = 30) and SREC
(N = 44) groups.
Parameters SSEC group
[N (%)]
SREC group
[N (%)]
P-value
Motile ability 15 (50.00) 7 (15.91) P < 0.01
Bioﬁlm formation 17 (56.67) 39 (88.64) P < 0.01
Table 2
Bacterial colony size, bacterial cell length and time of mid-log phase of
SSEC (N = 30) and SREC (N = 44) groups.
Groups Diameter of
bacterial colony
(mm)
Bacterial cell
length (mm)
Time of
mid-log phase of
growth curve (h)
SSEC
group
2.97 ± 0.09 1.53 ± 0.05* 3.91 ± 0.10
SREC
group
2.89 ± 0.10 1.35 ± 0.05 3.68 ± 0.09
*: Statistically signiﬁcant compared to SREC group (P < 0.05).4. Discussion
The results from this study indicated that the incidence of
bioﬁlm formation among SREC in UTI patients from the
northeast of Thailand is high (approximately 88.64%; 39 out of
44 isolates). This data were consistent with a previous report that
demonstrated bioﬁlm formation in 83% of uropathogenic E. coli
in South India [9]. In addition, our data supported this report
which indicated that bioﬁlm formation was correlated to
multidrug resistance, especially SXT resistance. The ability to
form a bioﬁlm in E. coli is an important factor in persistent
infection and resistance to antimicrobial agents [7,11].
The present study revealed that the SREC group had a shorter
bacterial cell length, higher frequencies of non-motility and
bioﬁlm formation than those of the SSEC group. The induction
of bioﬁlm formation in the SREC group would inevitably resultin these phenotypic changes. Bacteria within a bioﬁlm are
phenotypically different from their planktonic forms, and they
activate many genes that can alter their susceptibility to anti-
microbial agents [11,12].
In conclusion, the present study has shown that the incidence
of bioﬁlm formation among SREC in UTI patients from the
northeast of Thailand is high, and that bioﬁlm formation in these
E. coli isolates was associated with SXT resistance. The shorter
cell length of the SREC isolates indicated phenotypic change
that alters the susceptibility to antimicrobial agents. Further
study on the uropathogenic E. coli bioﬁlm formation may pro-
vide information about the mechanism of SXT resistance.
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